The Community Guide

- gsearch

Search Results

Narrow Results:

41 - 60 of 168485 Results

Refine Results

Refine Results:

Previous 1 2 3 4 ... 8425

Laboratory leadership competency framework

CITE Title : Laboratory leadership competency framework Corporate Authors(s) : Global Laboratory Leadership Programme.;World Health Organization.;Food and Agriculture Organization of the United Nations.;World Organisation for Animal Health.;European Centre for Disease Prevention and Control.;Centers for Disease Control and Prevention (U.S.);Association of Public Health Laboratories (U.S.); Published Date : 2019 Pages in Document : vi, 53 numbered pages URL : https://stacks.cdc.gov/view/cdc/111381 Global Laboratory Leadership Programme. (2019). Laboratory leadership competency framework. Global Laboratory Leadership Programme. "Laboratory leadership competency framework" (2019) Global Laboratory Leadership Programme. "Laboratory leadership competency framework" , 2019 Export RIS Citation Information.

:

Global Laboratory Leadership Programme. ...

2019

:

Laboratories are an essential and fundamental part of health systems and play a critical role in the detection, diagnosis, treatment and control of di...
Epidemic of poliomyelitis in Puerto Rico, 1960

CITE Title : Epidemic of poliomyelitis in Puerto Rico, 1960 Personal Author(s) : Timothee, Rafael A.;Morris, Leon;Feliberti, Manuel;Mainardi, Luis E.; Published Date : Jan 1963 Source : Public Health Rep. 78(1):65-76 URL : https://stacks.cdc.gov/view/cdc/73847 Timothee, Rafael A. et al. (1963). Epidemic of poliomyelitis in Puerto Rico, 1960. 78(1). Timothee, Rafael A. et al. "Epidemic of poliomyelitis in Puerto Rico, 1960" 78, no. 1 (1963) Timothee, Rafael A. et al. "Epidemic of poliomyelitis in Puerto Rico, 1960" vol. 78, no. 1, 1963 Export RIS Citation Information.

:

Timothee, Rafael A. ;

Morris, Leon

Jan 1963 | Public Health Rep. 78(1):65-76

No Description
Enhanced Meningococcal Disease Surveillance report, 2019 : confirmed and probable cases reported to the National Notifiable Diseases Surveillance System, 2019

CITE Title : Enhanced Meningococcal Disease Surveillance report, 2019 : confirmed and probable cases reported to the National Notifiable Diseases Surveillance System, 2019 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Office of Infectious Diseases. Published Date : September 30, 2021 Pages in Document : 2 unnumbered pages URL : https://stacks.cdc.gov/view/cdc/111382 National Center for Immunization and Respiratory Diseases (U.S.). Office of Infectious Diseases. (2021). Enhanced Meningococcal Disease Surveillance report, 2019 : confirmed and probable cases reported to the National Notifiable Diseases Surveillance System, 2019. National Center for Immunization and Respiratory Diseases (U.S.). Office of Infectious Diseases. "Enhanced Meningococcal Disease Surveillance report, 2019 : confirmed and probable cases reported to the National Notifiable Diseases Surveillance System, 2019" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Office of Infectious Diseases. "Enhanced Meningococcal Disease Surveillance report, 2019 : confirmed and probable cases reported to the National Notifiable Diseases Surveillance System, 2019" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Office of Infectious Diseases.

September 30, 2021

:

As part of Enhanced Meningococcal Disease Surveillance (EMDS), additional data and isolates were collected from 50 state and 3 large jurisdiction heal...
CDC’s National Public Health Institute Program

CITE Title : CDC’s National Public Health Institute Program Corporate Authors(s) : Center for Global Health (U.S.). Division of Global Health Protection. Published Date : September 2020 Pages in Document : 3 numbered pages URL : https://stacks.cdc.gov/view/cdc/111385 Center for Global Health (U.S.). Division of Global Health Protection. (2020). CDC’s National Public Health Institute Program. Center for Global Health (U.S.). Division of Global Health Protection. "CDC’s National Public Health Institute Program" (2020) Center for Global Health (U.S.). Division of Global Health Protection. "CDC’s National Public Health Institute Program" , 2020 Export RIS Citation Information.

:

Center for Global Health (U.S.). Division of Global Health Protection.

September 2020

:

The Centers for Disease Control and Prevention’s (CDC) Division of Global Health Protection (DGHP) collaborates with Ministries of Health (MoH) and ...
Utility of the Tourniquet Test and the White Blood Cell Count to Differentiate Dengue among Acute Febrile Illnesses in the Emergency Room

CITE Title : Utility of the Tourniquet Test and the White Blood Cell Count to Differentiate Dengue among Acute Febrile Illnesses in the Emergency Room Personal Author(s) : Gregory, Christopher J.;Lorenzi, Olga D.;Colón, Lisandra;Sepúlveda García, Arleene;Santiago, Luis M.;Cruz Rivera, Ramón;Cuyar Bermúdez, Liv Jossette;Ortiz Báez, Fernando;Vázquez Aponte, Delanor;Tomashek, Kay M.;Gutierrez, Jorge;Alvarado, Luisa; Published Date : Dec 06 2011 Source : PLoS Negl Trop Dis. 2011; 5(12). URL : https://stacks.cdc.gov/view/cdc/4245 Gregory, Christopher J. et al. (2011). Utility of the Tourniquet Test and the White Blood Cell Count to Differentiate Dengue among Acute Febrile Illnesses in the Emergency Room. 5(12). Gregory, Christopher J. et al. "Utility of the Tourniquet Test and the White Blood Cell Count to Differentiate Dengue among Acute Febrile Illnesses in the Emergency Room" 5, no. 12 (2011) Gregory, Christopher J. et al. "Utility of the Tourniquet Test and the White Blood Cell Count to Differentiate Dengue among Acute Febrile Illnesses in the Emergency Room" vol. 5, no. 12, 2011 Export RIS Citation Information.

:

Gregory, Christopher J. ;

Lorenzi, Olga D.

Dec 06 2011 | PLoS Negl Trop Dis. 2011; 5(12).

:

Dengue often presents with non-specific clinical signs, and given the current paucity of accurate, rapid diagnostic laboratory tests, identifying easi...
Genetics and Morphology of Aedes aegypti (Diptera: Culicidae) in Septic Tanks in Puerto Rico

CITE Title : Genetics and Morphology of Aedes aegypti (Diptera: Culicidae) in Septic Tanks in Puerto Rico Personal Author(s) : SOMERS, GERARD;BROWN, JULIA E.;BARRERA, ROBERTO;POWELL, JEFFREY R.; Published Date : Nov 2011 Source : J Med Entomol. 48(6):1095-1102 URL : https://stacks.cdc.gov/view/cdc/35268 SOMERS, GERARD et al. (2011). Genetics and Morphology of Aedes aegypti (Diptera: Culicidae) in Septic Tanks in Puerto Rico. 48(6). SOMERS, GERARD et al. "Genetics and Morphology of Aedes aegypti (Diptera: Culicidae) in Septic Tanks in Puerto Rico" 48, no. 6 (2011) SOMERS, GERARD et al. "Genetics and Morphology of Aedes aegypti (Diptera: Culicidae) in Septic Tanks in Puerto Rico" vol. 48, no. 6, 2011 Export RIS Citation Information.

:

SOMERS, GERARD ;

BROWN, JULIA E.

Nov 2011 | J Med Entomol. 48(6):1095-1102

:

Dengue viruses, primarily transmitted by the mosquito Aedes aegypti (L.), affect an estimated 50-100 million people yearly. Traditional approaches to ...
Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States

CITE Title : Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 5, 2021 URL : https://stacks.cdc.gov/view/cdc/111370 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 5, 2021

:

Updated Nov. 5, 2021On October 25, 2021 CDC amended its January 25, 2021 Order, titled, “Requirement for Proof of Negative COVID-19 Test or Recovery...
Key things to know about COVID-19 vaccines

CITE Title : Key things to know about COVID-19 vaccines Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 5, 2021 URL : https://stacks.cdc.gov/view/cdc/111368 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Key things to know about COVID-19 vaccines. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Key things to know about COVID-19 vaccines" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Key things to know about COVID-19 vaccines" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 5, 2021

:

Updated Nov. 5, 2021NOTICE: CDC now recommends that children between the ages of 5 and 11 years receive the Pfizer-BioNTech pediatric COVID-19 Vaccine...
Non-U.S. citizen, non-U.S. immigrants : air travel to the United States

CITE Title : Non-U.S. citizen, non-U.S. immigrants : air travel to the United States Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 5, 2021 URL : https://stacks.cdc.gov/view/cdc/111372 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Non-U.S. citizen, non-U.S. immigrants : air travel to the United States. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Non-U.S. citizen, non-U.S. immigrants : air travel to the United States" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Non-U.S. citizen, non-U.S. immigrants : air travel to the United States" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 5, 2021

:

Updated Nov. 5, 2021U.S. Citizens, U.S. Nationals, Lawful Permanent Residents, and ImmigrantsIf you are a U.S. citizen, U.S. national, lawful permanen...
COVID-19 vaccines for children and teens

CITE Title : COVID-19 vaccines for children and teens Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 4, 2021 URL : https://stacks.cdc.gov/view/cdc/111365 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). COVID-19 vaccines for children and teens. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 vaccines for children and teens" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 vaccines for children and teens" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 4, 2021

:

Updated Nov. 4, 2021Most Children and All Teens Can Get COVID-19 VaccinesCDC recommends everyone ages 5 and older get a COVID-19 vaccine to help prote...
International travel : information for U.S. citizens, U.S. nationals, U.S. lawful permanent residents, and immigrants

CITE Title : International travel : information for U.S. citizens, U.S. nationals, U.S. lawful permanent residents, and immigrants Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 5, 2021 URL : https://stacks.cdc.gov/view/cdc/111371 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). International travel : information for U.S. citizens, U.S. nationals, U.S. lawful permanent residents, and immigrants. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "International travel : information for U.S. citizens, U.S. nationals, U.S. lawful permanent residents, and immigrants" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "International travel : information for U.S. citizens, U.S. nationals, U.S. lawful permanent residents, and immigrants" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 5, 2021

:

Updated Nov. 5, 2021
Selected adverse events reported after COVID-19 vaccination

CITE Title : Selected adverse events reported after COVID-19 vaccination Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 5, 2021 URL : https://stacks.cdc.gov/view/cdc/111367 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Selected adverse events reported after COVID-19 vaccination. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Selected adverse events reported after COVID-19 vaccination" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Selected adverse events reported after COVID-19 vaccination" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 5, 2021

:

Updated Nov. 5, 2021NOTICE: CDC now recommends that children between the ages of 5 and 11 years receive the Pfizer-BioNTech pediatric COVID-19 Vaccine...
COVID-19 vaccine monitoring systems for pregnant people

CITE Title : COVID-19 vaccine monitoring systems for pregnant people Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 5, 2021 URL : https://stacks.cdc.gov/view/cdc/111366 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). COVID-19 vaccine monitoring systems for pregnant people. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 vaccine monitoring systems for pregnant people" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 vaccine monitoring systems for pregnant people" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 5, 2021

:

Updated Nov. 5, 2021NOTICE: CDC now recommends that children between the ages of 5 and 11 years receive the Pfizer-BioNTech pediatric COVID-19 Vaccine...
TRAVELING TO THE UNITED STATES FROM A FOREIGN COUNTRY BY AIR

CITE Title : TRAVELING TO THE UNITED STATES FROM A FOREIGN COUNTRY BY AIR Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : Nov. 5, 2021 Pages in Document : 1 poster URL : https://stacks.cdc.gov/view/cdc/111369 Centers for Disease Control and Prevention (U.S.) (2021). TRAVELING TO THE UNITED STATES FROM A FOREIGN COUNTRY BY AIR. Centers for Disease Control and Prevention (U.S.) "TRAVELING TO THE UNITED STATES FROM A FOREIGN COUNTRY BY AIR" (2021) Centers for Disease Control and Prevention (U.S.) "TRAVELING TO THE UNITED STATES FROM A FOREIGN COUNTRY BY AIR" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

Nov. 5, 2021

:

CS327569-DPublication date from document properties.requirements-travel-to-us-by-air-quick-reference-p.pdf
Stop the spread of germs during travel

CITE Title : Stop the spread of germs during travel Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : September 17, 2020 Pages in Document : 1 poster URL : https://stacks.cdc.gov/view/cdc/111359 Centers for Disease Control and Prevention (U.S.) (2020). Stop the spread of germs during travel. Centers for Disease Control and Prevention (U.S.) "Stop the spread of germs during travel" (2020) Centers for Disease Control and Prevention (U.S.) "Stop the spread of germs during travel" , 2020 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

September 17, 2020

:

CS320259-A September 17, 2020 2:52 PMCOVID_StopSptread_TravelPoster_v4.pdf
Humoral signatures of protective and pathological SARS-CoV-2 infection in children

CITE Title : Humoral signatures of protective and pathological SARS-CoV-2 infection in children Personal Author(s) : Bartsch, Yannic C;Wang, Chuangqi;Zohar, Tomer;Fischinger, Stephanie;Atyeo, Caroline;Burke, John;Kang, Jaewon;Edlow, Andrea G;Fasano, Alessio;Baden, Lindsey R;Nilles, Eric J;Woolley, Ann E;Karlson, Elizabeth Wood;Hopke, Alex R;Irimia, Daniel;Fischer, Eric S;Ryan, Edward T.;Charles, Richelle;Julg, Boris D.;Lauffenburger, Douglas A;Yonker, Lael M;Alter, Galit; Published Date : March 2021 Source : Nat Med. 27(3):454-462 URL : https://stacks.cdc.gov/view/cdc/108324 Bartsch, Yannic C et al. (2021). Humoral signatures of protective and pathological SARS-CoV-2 infection in children. 27(3). Bartsch, Yannic C et al. "Humoral signatures of protective and pathological SARS-CoV-2 infection in children" 27, no. 3 (2021) Bartsch, Yannic C et al. "Humoral signatures of protective and pathological SARS-CoV-2 infection in children" vol. 27, no. 3, 2021 Export RIS Citation Information.

:

Bartsch, Yannic C ;

Wang, Chuangqi

March 2021 | Nat Med. 27(3):454-462

:

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic continues to spread relentlessly, associated with a high frequency of respir...
Operational considerations for personal protective equipment in the context of global shortages for COVID-19 pandemic

CITE Title : Operational considerations for personal protective equipment in the context of global shortages for COVID-19 pandemic Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : Jun 3, 2021 URL : https://stacks.cdc.gov/view/cdc/111296 Centers for Disease Control and Prevention (U.S.) (2021). Operational considerations for personal protective equipment in the context of global shortages for COVID-19 pandemic. Centers for Disease Control and Prevention (U.S.) "Operational considerations for personal protective equipment in the context of global shortages for COVID-19 pandemic" (2021) Centers for Disease Control and Prevention (U.S.) "Operational considerations for personal protective equipment in the context of global shortages for COVID-19 pandemic" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

Jun 3, 2021

:

Intended for use in non-US healthcare settingsPublication date from document properties.emergency-considerations-ppe-508.pdf
Epidemiology of cytomegalovirus Infection among mothers and infants in Colombia

CITE Title : Epidemiology of cytomegalovirus Infection among mothers and infants in Colombia Personal Author(s) : Rico, Angelica;Dollard, Sheila C.;Valencia, Diana;Corchuelo, Sheryll;Tong, Van T.;Laiton-Donato, Katherine;Amin, Minal M.;Benavides, Monica;Wong, Phili;Newton, Suzanne;Daza, Marcela;Cates, Jordan;Gonzalez, Maritza;Zambrano, Laura D.;Mercado, Marcela M.;Ailes, Elizabeth C.;Rodriguez, Helena M.;Gilboa, Suzanne M.;Acosta, Jacqueline;Ricaldi, Jessica;Pelaez, Dioselina;Honein, Margaret A.;Ospina, Martha L.;Lanzieri, Tatiana M.; Published Date : 11-2021 Source : J Med Virol. 93(11):6393-6397 URL : https://stacks.cdc.gov/view/cdc/110256 Rico, Angelica et al. (2021). Epidemiology of cytomegalovirus Infection among mothers and infants in Colombia. 93(11). Rico, Angelica et al. "Epidemiology of cytomegalovirus Infection among mothers and infants in Colombia" 93, no. 11 (2021) Rico, Angelica et al. "Epidemiology of cytomegalovirus Infection among mothers and infants in Colombia" vol. 93, no. 11, 2021 Export RIS Citation Information.

:

Rico, Angelica ;

Dollard, Sheila C.

11-2021 | J Med Virol. 93(11):6393-6397

:

We assessed maternal and infant cytomegalovirus (CMV) infection in Colombia. Maternal serum was tested for CMV immunoglobulin G antibodies at a median...
Operational considerations for personal protective equipment in the context of global supply shortages for coronavirus disease 2019 (COVID-19) pandemic : non-US healthcare settings

CITE Title : Operational considerations for personal protective equipment in the context of global supply shortages for coronavirus disease 2019 (COVID-19) pandemic : non-US healthcare settings Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 4, 2021 URL : https://stacks.cdc.gov/view/cdc/111311 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Operational considerations for personal protective equipment in the context of global supply shortages for coronavirus disease 2019 (COVID-19) pandemic : non-US healthcare settings. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Operational considerations for personal protective equipment in the context of global supply shortages for coronavirus disease 2019 (COVID-19) pandemic : non-US healthcare settings" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Operational considerations for personal protective equipment in the context of global supply shortages for coronavirus disease 2019 (COVID-19) pandemic : non-US healthcare settings" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 4, 2021

:

Updated Nov. 4, 2021The Centers for Disease Control and Prevention (CDC) is working closely with international partners to respond to the coronavirus ...
Rhode Island viral hepatitis & liver cancer prevention profile

CITE Title : Rhode Island viral hepatitis & liver cancer prevention profile Corporate Authors(s) : National Center for HIV/AIDS, Viral Hepatitis, STD, and TB (U.S.). Division of Viral Hepatitis.;George Washington University Cancer Center.; Published Date : Mar 23, 2018 Pages in Document : 1 unnumbered page URL : https://stacks.cdc.gov/view/cdc/111184 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB (U.S.). Division of Viral Hepatitis. (2018). Rhode Island viral hepatitis & liver cancer prevention profile. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB (U.S.). Division of Viral Hepatitis. "Rhode Island viral hepatitis & liver cancer prevention profile" (2018) National Center for HIV/AIDS, Viral Hepatitis, STD, and TB (U.S.). Division of Viral Hepatitis. "Rhode Island viral hepatitis & liver cancer prevention profile" , 2018 Export RIS Citation Information.

:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB (U.S.). Division of Viral Hepatitis. ...

Mar 23, 2018

:

Each year in the United States, around 31,000 people get liver cancer. Did you know that among people with certain liver cancers in the United States,...

41 - 60 / 168485

Previous 1 2 3 4 ... 8425